The question is whether the UK regulators were simply inept or whether they knowingly and deliberately assisted GlaxoSmithKline to deceive clinicians and the public.
"The regulators seem stuck in a world where balancing evidence of potential benefit against actual risk causes real problems"
GSK documents now acknowledge a possible six-fold suicide risk for adults on Paxil:
A 2003 enquiry by the regulator was halted when it emerged that half the members of the so called "expert group" held shares in GSK.
"Following the path of least resistance
is what makes rivers and men crooked."